PSMA PET/CT Versus mpMRI for the Detection of Clinically Significant Prostate Cancer: An Updated Overview

被引：6
|
作者：
Caracciolo, Matteo [1 ]
Castello, Angelo [2 ]
Lopci, Egesta [3 ,4 ]
机构：
[1] Univ Hosp Ferrara, Oncol Med & Specialists Dept, Nucl Med Unit, Ferrara, Italy
[2] Fdn IRCCS CaGranda, Osped Maggiore Policlin, Nucl Med Unit, Milan, Italy
[3] IRCCS, Human Res Hosp, Nucl Med Unit, Milan, Italy
[4] IRCCS, Human Res Hosp, Nucl Med Unit, Via Manzoni 56, I-20089 Milan, Italy
来源：
SEMINARS IN NUCLEAR MEDICINE | 2024年 / 54卷 / 01期
关键词：
GA-68-PSMA PET/CT; DIAGNOSTIC-ACCURACY; BIOPSY; VALIDATION; MRI; PSA;
D O I：
10.1053/j.semnuclmed.2023.10.002
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
In the last years, PSMA-PET imaging and multiparametric MRI (mpMRI) have improved the clinical management of prostate cancer (PCa) patients. Currently, mpMRI is recommended by the EAU (European Association of Urology) guidelines for the primary diagnosis of PCa, whereas PSMA-PET is reserved for disease staging, particularly in high risk localized or locally advanced disease, as well as for biochemical recurrence after surgery. Nevertheless, several studies have explored the added value of PSMA-PET in other clinical scenar-ios, including primary diagnosis and especially for the detection of clinically significant PCa (csPCa). In the present contribution, we will provide an overview and an update on the cur-rent literature on imaging detection of csPCa, with a particular focus on mpMRI, PSMA-PET and their comparison. Semin Nucl Med 54:30-38 (c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码：30 / 38
页数：9
相关论文
共 50 条
  • [1] Comparison of MRI, PSMA PET/CT, and Fusion PSMA PET/MRI for Detection of Clinically Significant Prostate Cancer
    Arslan, Aydan
    Karaarslan, Ercan
    Guner, A. Levent
    Saglican, Yesim
    Tuna, Mustafa Bilal
    Ozisik, Ozan
    Kural, Ali Riza
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2021, 45 (02) : 210 - 217
  • [2] Detection Rate of 68Ga-PSMA PET/CT vs. mpMRI Targeted Biopsy for Clinically Significant Prostate Cancer
    Pepe, Pietro
    Pepe, Ludovica
    Cosentino, Sebastiano
    Ippolito, Massimo
    Pennisi, Michele
    Fraggetta, Filippo
    ANTICANCER RESEARCH, 2022, 42 (06) : 3011 - 3015
  • [3] Comparing detection rates of PSMA PET/CT target biopsy vs. mpMRI targeted biopsy in detection of clinically significant prostate cancer
    Piramide, F.
    Cisero, E.
    Amparore, D.
    Checcucci, E.
    De Cillis, S. T.
    Piana, A.
    Volpi, G.
    Sica, M.
    Verri, P.
    Burgio, M.
    Meziere, J.
    Quara, A.
    Busacca, G.
    Sterrantino, A.
    Ortenzi, M.
    Mesterca, A. G.
    Mandaletti, M.
    Bignante, G.
    Garino, D.
    Rosi, F.
    Manfredi, M.
    Di Dio, M.
    Fiori, C.
    Porpiglia, F.
    EUROPEAN UROLOGY, 2024, 85 : S1109 - S1109
  • [4] The role of PSMA PET/CT in the diagnosis of clinically significant prostate cancer
    Kibar, A.
    Sahin, O. E.
    Asa, S.
    Demirbilek, M.
    Bilgic, S.
    Onal, B.
    Kabasakal, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S15 - S16
  • [5] PSMA PET/CT for Primary Staging of Prostate Cancer- An Updated Overview
    Jochumsen, Mads Ryo
    Bouchelouche, Kirsten
    SEMINARS IN NUCLEAR MEDICINE, 2024, 54 (01) : 39 - 45
  • [6] Multiparametric MRI and 18F-PSMA-1007 PET/CT for the Detection of Clinically Significant Prostate Cancer
    Prive, Bastiaan M.
    Israel, Bas
    Janssen, Marcel J. R.
    van der Leest, Marloes M. G.
    de Rooij, Maarten
    van Ipenburg, Jolique A.
    Jonker, Marianne
    Peters, Steffie M. B.
    de Groot, Michel
    Zamecnik, Patrik
    Hoepping, Alexander
    Bomers, Joyce G.
    Gotthardt, Martin
    Sedelaar, J. P. Michiel
    Barentsz, Jelle O.
    van Oort, Inge M.
    Nagarajah, James
    RADIOLOGY, 2024, 311 (02)
  • [7] Clinical, pathological and imaging variables associated with prostate cancer detection by PSMA PET/CT and mpMRI
    Sonni, I.
    Weiner, A. B.
    Doddipalli, S.
    Deol, M.
    Ban, D.
    Kim, H.
    Grogan, T.
    Ahuja, P.
    Barroso, N.
    Zong, Y.
    Soin, P.
    Sisk, A.
    Czernin, J.
    Hsu, W.
    Calais, J.
    Reiter, R. E.
    Raman, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S524 - S524
  • [8] COMPARING PSMA-PET/CT TO MPMRI AND HISTOPATHOLOGY FOR STAGING PROSTATE CANCER
    Berger, Israel
    Annabattula, Chandra
    Lewis, Jeffrey
    Shetty, Deepa V.
    Winter, Matthew
    Loh, Han
    Varol, Celi
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 51 - 51
  • [9] Comparative study of 68Ga-PSMA PET/CT and multiparametric MRI in detection of clinically significant prostate cancer
    Meng, X.
    Kang, F.
    Quan, Z.
    Wang, M.
    Han, T.
    Wang, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S494 - S495
  • [10] Comparisons of mpMRI, 68Ga-PSMA PET/CT and mpMRI combined with 68Ga-PSMA PET/CT in diagnosing prostate cancer based on tumor detection, localization and staging
    Mai, Zhipeng
    Zhu, Ming
    Feng, Tianrui
    Zhou, Zhien
    Zhou, Yi
    Wang, Dong
    Yuan, Runqiang
    Xiao, Yu
    Wang, Jiarou
    Sun, Hao
    Yan, Weigang
    WORLD JOURNAL OF UROLOGY, 2024, 42 (01)
12345